Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

65.0K
Overview
65.0K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

849
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

955
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
955
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

647
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
647

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease.

EBioMedicine·2023
Same author

Inhibition of thrombin on endothelium enhances recruitment of regulatory T cells during IRI and when combined with adoptive Treg transfer, significantly protects against acute tissue injury and prolongs allograft survival.

Frontiers in immunology·2023
Same author

Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with <sup>89</sup>Zr-oxine for Medium-Term <i>In Vivo</i> Cell Tracking.

Molecules (Basel, Switzerland)·2023
Same author

Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients.

Clinical kidney journal·2022
Same author

Navigating COVID-19 in Renal Transplantation: From "Alpha" to "Omicron"; A Single-center Experience.

Transplantation·2022
Same author

Nox2-deficient Tregs improve heart transplant outcomes via their increased graft recruitment and enhanced potency.

JCI insight·2021
Same journal

Atypical renal phenotype with tubular proteinuria and hypercalciuria in siblings with nail-patella syndrome: evidence for a dual genetic diagnosis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Blood pressure control in pediatric hemodialysis: data from the SCOPE collaborative.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Correlation between urinary soluble CD163 and endocapillary proliferation and fibrinoid necrosis in IgA vasculitis with nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

SGLT2i, anti-endothelin A and double endothelin and angiotensin inhibitors: a new future for chronic kidney disease in children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The role of urinary trehalase levels in the early diagnosis of acute kidney injury in dehydrated children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Neuron-specific enolase and brain-derived neurotrophic factor as developmental neurovascular markers in chronic kidney disease and kidney transplantation.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

13.8K

Transplantation tolerance.

Emma M Salisbury1, David S Game, Robert I Lechler

  • 1Section of Immunobiology, Division of Immunology and Inflammation, Department of Medicine, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington Campus, Exhibition Road, London, SW7 2AZ, UK, emmasalisbury@doctors.org.uk.

Pediatric Nephrology (Berlin, Germany)
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Achieving immune tolerance in organ transplantation is possible, moving beyond immunosuppressive drugs. Research explores basic science and clinical advances for long-term graft survival.

More Related Videos

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

11.7K
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

12.9K

Related Experiment Videos

Last Updated: May 6, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

13.8K
Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

11.7K
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

12.9K

Area of Science:

  • Immunology
  • Transplantation Medicine

Background:

  • Organ transplantation faces challenges with immunosuppressive drugs causing morbidity and poor long-term graft survival.
  • Current immunosuppressive regimens carry risks of infection, cardiovascular disease, malignancy, and graft loss.
  • Historical and experimental data suggest that achieving transplant tolerance is fundamentally possible.

Purpose of the Study:

  • To explore the basic science underlying immune tolerance mechanisms in transplantation.
  • To review the latest clinical advances in achieving transplantation tolerance.
  • To address the complexities of translating immune tolerance into clinical practice.

Main Methods:

  • Review of existing literature on transplantation immunology and tolerance.
  • Analysis of experimental models demonstrating immune tolerance.
  • Examination of clinical case reports and trials related to immunosuppression withdrawal and tolerance.

Main Results:

  • Evidence supports the feasibility of immune tolerance in organ transplantation.
  • Understanding the complex mechanisms of tolerance is crucial for clinical application.
  • Clinical translation of tolerance strategies remains a significant challenge.

Conclusions:

  • Moving beyond broad-spectrum immunosuppression towards tolerance is a key goal in transplantation.
  • Further research into basic science and clinical strategies is needed to overcome barriers to tolerance.
  • Successful induction of immune tolerance promises improved long-term graft survival and reduced patient morbidity.